Vyepti
NDC 67386-130, eptinezumab-jjmr, injection, from Lundbeck Pharmaceuticals LLC.
- Product NDC
- 67386-130
- Status
- Listed
- Labeler
- Lundbeck Pharmaceuticals LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761119
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67386-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EPTINEZUMAB100 mg/mL
Pharmacologic classes
Calcitonin Gene-related Peptide Antagonist [EPC]; Calcitonin Gene-related Peptide Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67386-130-51 | 67386013051 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-51) / 1 mL in 1 VIAL, SINGLE-DOSE |
| 67386-130-91 | 67386013091 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67386-130-91) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/79065861-6aa5-4d1f-829f-3a6471286b36Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67386-130
Use it
Look up 67386-130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67386-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67386-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.